|
2025-03-10 |
2025-03-10 |
S
Sale
|
Higa Tomohiro
SVP, Finance
Officer
|
845
-0.8%
0.54
USD 455
|
845
-0.8%
|
0.54
|
USD 455
|
|
|
2025-03-10 |
2025-03-10 |
S
Sale
|
Higa Tomohiro
SVP, Finance
Officer
|
620
-0.6%
0.54
USD 334
|
620
-0.6%
|
0.54
|
USD 334
|
|
|
2025-03-10 |
2025-03-10 |
S
Sale
|
Higa Tomohiro
SVP, Finance
Officer
|
1,017
-1.0%
0.54
USD 548
|
1,017
-1.0%
|
0.54
|
USD 548
|
|
|
2025-03-10 |
2025-03-10 |
S
Sale
|
Ali Faraz
Chief Executive Officer
Executive Director
|
3,947
-1.2%
0.54
USD 2,125
|
3,947
-1.2%
|
0.54
|
USD 2,125
|
|
|
2025-03-10 |
2025-03-10 |
S
Sale
|
Ali Faraz
Chief Executive Officer
Executive Director
|
5,794
-1.8%
0.54
USD 3,119
|
5,794
-1.8%
|
0.54
|
USD 3,119
|
|
|
2025-03-10 |
2025-03-10 |
S
Sale
|
Tingley Whittemore
Chief Medical Officer
Officer
|
1,598
-0.9%
0.54
USD 860
|
1,598
-0.9%
|
0.54
|
USD 860
|
|
|
2025-03-10 |
2025-03-10 |
S
Sale
|
Tingley Whittemore
Chief Medical Officer
Officer
|
4,073
-2.3%
0.54
USD 2,193
|
4,073
-2.3%
|
0.54
|
USD 2,193
|
|
|
2025-03-10 |
2025-03-10 |
PS
Planned sale
|
Tingley Whittemore
Chief Medical Officer
Officer
|
1,727
-0.9%
0.54
USD 930
|
1,727
-0.9%
|
0.54
|
USD 930
|
|
|
2025-03-07 |
2025-03-05 |
B
Purchase
|
COLUMN GROUP III GP, LP
Large shareholder
|
35,714,284
+262.6%
0.70
USD 24,999,999
|
35,714,284
+262.6%
|
0.70
|
USD 24,999,999
|
|
|
2025-03-07 |
2025-03-05 |
B
Purchase
|
GOEDDEL DAVID V
Non-Executive Director
Large shareholder
|
35,714,284
+262.6%
0.70
USD 24,999,999
|
35,714,284
+262.6%
|
0.70
|
USD 24,999,999
|
|
|
2024-11-18 |
2024-11-18 |
S
Sale
|
Saito Chihiro
SVP, Accounting and Fin. Ops.
Officer
|
2,258
-3.6%
2.12
USD 4,787
|
2,258
-3.6%
|
2.12
|
USD 4,787
|
|
|
2024-08-19 |
2024-08-16 |
S
Sale
|
Saito Chihiro
SVP, Accounting and Fin. Ops.
Officer
|
807
-1.3%
2.89
USD 2,336
|
807
-1.3%
|
2.89
|
USD 2,336
|
|
|
2024-08-19 |
2024-08-16 |
S
Sale
|
Saito Chihiro
SVP, Accounting and Fin. Ops.
Officer
|
654
-1.0%
2.89
USD 1,893
|
654
-1.0%
|
2.89
|
USD 1,893
|
|
|
2024-08-19 |
2024-08-16 |
S
Sale
|
Saito Chihiro
SVP, Accounting and Fin. Ops.
Officer
|
902
-1.4%
2.89
USD 2,611
|
902
-1.4%
|
2.89
|
USD 2,611
|
|
|
2024-08-16 |
2024-08-16 |
PS
Planned sale
|
Tingley Whittemore
Chief Medical Officer
Officer
|
1,625
-1.5%
2.89
USD 4,704
|
1,625
-1.5%
|
2.89
|
USD 4,704
|
|
|
2024-08-16 |
2024-08-16 |
PS
Planned sale
|
Tingley Whittemore
Chief Medical Officer
Officer
|
5,803
-5.1%
2.89
USD 16,797
|
5,803
-5.1%
|
2.89
|
USD 16,797
|
|
|
2024-08-16 |
2024-08-16 |
S
Sale
|
Ali Faraz
Chief Executive Officer
Executive Director
|
3,946
-2.1%
2.89
USD 11,422
|
3,946
-2.1%
|
2.89
|
USD 11,422
|
|
|
2024-08-16 |
2024-08-16 |
S
Sale
|
Ali Faraz
Chief Executive Officer
Executive Director
|
5,802
-2.9%
2.89
USD 16,794
|
5,802
-2.9%
|
2.89
|
USD 16,794
|
|
|
2024-03-06 |
2024-03-05 |
PS
Planned sale
|
Hoey Timothy
Chief Scientific Officer
Officer
|
3,300
-1.3%
7.00
USD 23,101
|
3,300
-1.3%
|
7.00
|
USD 23,101
|
|
|
2024-02-21 |
2024-02-20 |
PS
Planned sale
|
Hoey Timothy
Chief Scientific Officer
Officer
|
200
-0.1%
6.17
USD 1,233
|
200
-0.1%
|
6.17
|
USD 1,233
|
|
|
2024-02-21 |
2024-02-20 |
PS
Planned sale
|
Hoey Timothy
Chief Scientific Officer
Officer
|
6,369
-2.6%
5.31
USD 33,813
|
6,369
-2.6%
|
5.31
|
USD 33,813
|
|
|
2024-02-16 |
2024-02-16 |
PS
Planned sale
|
Tingley Whittemore
Chief Medical Officer
Officer
|
6,500
-8.1%
5.86
USD 38,090
|
6,500
-8.1%
|
5.86
|
USD 38,090
|
|
|
2024-02-16 |
2024-02-16 |
PS
Planned sale
|
PATTERSON LEONE D
Chief Fin. and Bus. Officer
Officer
|
5,201
-7.9%
5.86
USD 30,478
|
5,201
-7.9%
|
5.86
|
USD 30,478
|
|
|
2024-02-16 |
2024-02-16 |
S
Sale
|
Ali Faraz
Chief Executive Officer
Executive Director
|
6,358
-5.3%
5.86
USD 37,258
|
6,358
-5.3%
|
5.86
|
USD 37,258
|
|
|
2024-02-16 |
2024-02-16 |
S
Sale
|
Hoey Timothy
Chief Scientific Officer
Officer
|
4,681
-1.9%
5.86
USD 27,431
|
4,681
-1.9%
|
5.86
|
USD 27,431
|
|
|
2024-02-14 |
2024-02-12 |
B
Purchase
|
GOEDDEL DAVID V
Non-Executive Director
Large shareholder
|
2,222,222
+19.5%
4.50
USD 9,999,999
|
2,222,222
+19.5%
|
4.50
|
USD 9,999,999
|
|
|
2024-02-14 |
2024-02-12 |
B
Purchase
|
COLUMN GROUP III GP, LP
Large shareholder
|
2,222,222
+19.5%
4.50
USD 9,999,999
|
2,222,222
+19.5%
|
4.50
|
USD 9,999,999
|
|
|
2023-08-29 |
2023-08-29 |
PS
Planned sale
|
Hoey Timothy
Chief Scientific Officer
Officer
|
7,243
-2.8%
4.26
USD 30,855
|
7,243
-2.8%
|
4.26
|
USD 30,855
|
|
|
2023-08-18 |
2023-08-16 |
PS
Planned sale
|
Tingley Whittemore
Chief Medical Officer
Officer
|
5,563
-6.8%
3.81
USD 21,195
|
5,563
-6.8%
|
3.81
|
USD 21,195
|
|
|
2023-08-18 |
2023-08-16 |
S
Sale
|
Ali Faraz
Chief Executive Officer
Executive Director
|
5,563
-4.5%
3.81
USD 21,195
|
5,563
-4.5%
|
3.81
|
USD 21,195
|
|
|
2023-08-18 |
2023-08-16 |
S
Sale
|
Hoey Timothy
Chief Scientific Officer
Officer
|
4,007
-1.5%
3.81
USD 15,267
|
4,007
-1.5%
|
3.81
|
USD 15,267
|
|
|
2023-08-18 |
2023-08-16 |
PS
Planned sale
|
PATTERSON LEONE D
Chief Fin. and Bus. Officer
Officer
|
4,452
-6.5%
3.81
USD 16,962
|
4,452
-6.5%
|
3.81
|
USD 16,962
|
|
|
2023-03-14 |
2023-03-10 |
B
Purchase
|
GOEDDEL DAVID V
Non-Executive Director
Large shareholder
|
6,779
+0.1%
2.60
USD 17,596
|
6,779
+0.1%
|
2.60
|
USD 17,596
|
|
|
2023-03-14 |
2023-03-10 |
B
Purchase
|
COLUMN GROUP III GP, LP
Large shareholder
|
6,779
+0.1%
2.60
USD 17,596
|
6,779
+0.1%
|
2.60
|
USD 17,596
|
|
|
2023-02-10 |
2023-02-08 |
B
Purchase
|
GOEDDEL DAVID V
Non-Executive Director
Large shareholder
|
1,500,000
+15.2%
2.60
USD 3,900,000
|
1,500,000
+15.2%
|
2.60
|
USD 3,900,000
|
|
|
2023-02-10 |
2023-02-08 |
B
Purchase
|
COLUMN GROUP III GP, LP
Large shareholder
|
1,500,000
+15.2%
2.60
USD 3,900,000
|
1,500,000
+15.2%
|
2.60
|
USD 3,900,000
|
|
|
2023-01-23 |
2023-01-19 |
B
Purchase
|
COLUMN GROUP III GP, LP
Large shareholder
|
69,739
+0.7%
2.50
USD 174,201
|
69,739
+0.7%
|
2.50
|
USD 174,201
|
|
|
2023-01-23 |
2023-01-19 |
B
Purchase
|
GOEDDEL DAVID V
Non-Executive Director
Large shareholder
|
69,739
+0.7%
2.50
USD 174,201
|
69,739
+0.7%
|
2.50
|
USD 174,201
|
|
|
2023-01-19 |
2023-01-18 |
B
Purchase
|
COLUMN GROUP III GP, LP
Large shareholder
|
135,688
+1.4%
2.52
USD 341,432
|
135,688
+1.4%
|
2.52
|
USD 341,432
|
|
|
2023-01-19 |
2023-01-18 |
B
Purchase
|
GOEDDEL DAVID V
Non-Executive Director
Large shareholder
|
135,688
+1.4%
2.52
USD 341,432
|
135,688
+1.4%
|
2.52
|
USD 341,432
|
|
|
2023-01-19 |
2023-01-17 |
B
Purchase
|
COLUMN GROUP III GP, LP
Large shareholder
|
49,463
+0.5%
2.49
USD 123,395
|
49,463
+0.5%
|
2.49
|
USD 123,395
|
|
|
2023-01-19 |
2023-01-17 |
B
Purchase
|
GOEDDEL DAVID V
Non-Executive Director
Large shareholder
|
49,463
+0.5%
2.49
USD 123,395
|
49,463
+0.5%
|
2.49
|
USD 123,395
|
|
|
2022-12-09 |
2022-11-21 |
B
Purchase
|
Srivastava Deepak
Non-Executive Director
|
230,769
+162.9%
2.60
USD 599,999
|
230,769
+162.9%
|
2.60
|
USD 599,999
|
|
|
2022-11-23 |
2022-11-21 |
B
Purchase
|
GOEDDEL DAVID V
Non-Executive Director
Large shareholder
|
9,615,384
+inf%
2.60
USD 24,999,998
|
9,615,384
+inf%
|
2.60
|
USD 24,999,998
|
|
|
2022-11-23 |
2022-11-21 |
B
Purchase
|
COLUMN GROUP III GP, LP
Large shareholder
|
9,615,384
+inf%
2.60
USD 24,999,998
|
9,615,384
+inf%
|
2.60
|
USD 24,999,998
|
|
|
2022-11-25 |
2022-11-17 |
B
Purchase
|
Casdin Eli
Non-Executive Director
|
2,492,042
+69.5%
2.60
USD 6,479,309
|
2,492,042
+69.5%
|
2.60
|
USD 6,479,309
|
|
|
2022-04-28 |
2022-04-26 |
PS
Planned sale
|
Hoey Timothy
Chief Scientific Officer
Officer
|
1,353
-0.7%
10.13
USD 13,706
|
1,353
-0.7%
|
10.13
|
USD 13,706
|
|
